The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Open accessAbstract
To examine the activity of matrix metalloproteinases (MMPs) and aggrecanase in control and diseased human articular cartilage, metabolic fragments of aggrecan were detected with monospecific antipeptide antibodies. The distribution and quantity of MMP-generated aggrecan G1 fragments terminating in VDIPEN341 were compared with the distribution of aggrecanase-generated G1 fragments terminating in NITEGE373. Both types of G1 fragments were isolated from osteoarthritic cartilage. The sizes were consistent with a single enzymatic cleavage in the interglobular domain region, with no further proteolytic processing of these fragments. Both neoepitopes were also detected by immunohistochemistry in articular cartilage from patients undergoing joint replacement for osteoarthritis (OA), rheumatoid arthritis (RA), and in cartilage from adults with no known joint disease. In control specimens, the staining intensity for both G1 fragments increased with age, with little staining in cartilage from 22-wk-old fetal samples. There was also an increase with age in the extracted amount of MMP-generated neoepitope in relation to both aggrecan and collagen content, confirming the immunohistochemical results. After the age of 20-30 yr this relationship remained at a steady state. The staining for the MMP-generated epitope was most marked in control cartilage exhibiting histological signs of damage, whereas intense staining for the aggrecanase-generated fragment was often noted in adult cartilage lacking overt histological damage. Intense staining for both neoepitopes appeared in the more severely fibrillated, superficial region of the tissue. Intense immunostaining for both VDIPEN- and NITEGE- neoepitopes was also detected in joint cartilage from patients with OA or RA. Cartilage in these specimens was significantly more degraded and high levels of staining for both epitopes was always seen in areas with extensive cartilage damage. The levels of extracted VDIPEN neoepitope relative to collagen or aggrecan in both OA and RA samples were similar to those seen in age-matched control specimens. Immunostaining for both types of aggrecan fragments was seen surrounding the cells but also further removed in the interterritorial matrix. In some regions of the tissue, both neoepitopes were found while in others only one was detected. Thus, generation and/or turnover of these specific catabolic aggrecan fragments is not necessarily coordinated. Our results are consistent with the presence in both normal and arthritic joint cartilage of proteolytic activity against aggrecan based on both classical MMPs and "aggrecanase."
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY
MCLEAN, I. W., & NAKANE, P. K. (1974) · Journal of Histochemistry & Cytochemistry · doi:10.1177/22.12.1077 · Cited by 3,798
Charalambous, C. P. (2014) · Classic Papers in Orthopaedics · doi:10.1007/978-1-4471-5451-8_97 · Cited by 1,835
The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system
Shu, S., Ju, G., & Fan, L. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90346-1 · Cited by 1,227
Mankin, H. J., Dorfman, H., Lippiello, L., & Zarins, A. (1971) · PubMed · Cited by 796
Hollander, A. P., Heathfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
Dean, D. D., Martel-Pelletier, J., Pelletier, J. P., Howell, D. S., & Woessner, J. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114215 · Cited by 598
Hollander, A. P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R., & Poole, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118357 · Cited by 485
Doege, K. J., Sasaki, M., Kimura, T., & Yamada, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35257-2 · Cited by 446
Stefan Lohmander, L., Neame, P. J., & Sandy, J. D. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360906 · Cited by 431
Cited by
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Structure and function of aggrecan
KIANI, C., CHEN, L., WU, Y. J., YEE, A. J., & YANG, B. B. (2002) · Cell Research · doi:10.1038/sj.cr.7290106 · Cited by 758
The role of the chondrocyte in osteoarthritis
Goldring, M. B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1916::aid-anr2>3.0.co;2-i · Cited by 713
Knudson, C. B., & Knudson, W. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0243 · Cited by 600
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
The role of the cartilage matrix in osteoarthritis
Heinegård, D., & Saxne, T. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.198 · Cited by 553
Lecaille, F., Kaleta, J., & Brömme, D. (2002) · Chemical Reviews · doi:10.1021/cr0101656 · Cited by 519
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
Matrix Metalloproteinases And Aggrecanase: Their Role in Disorders of the Human Intervertebral Disc
Roberts, S., Caterson, B., Menage, J., Evans, E. H., Jaffray, D. C., & Eisenstein, S. M. (2000) · Spine · doi:10.1097/00007632-200012010-00007 · Cited by 500
Kobayashi, M., Squires, G. R., Mousa, A., Tanzer, M., Zukor, D. J., Antoniou, J., Feige, U., & Poole, A. R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20776 · Cited by 497
Maldonado, M., & Nam, J. (2013) · BioMed Research International · doi:10.1155/2013/284873 · Cited by 487
Basic Science of Articular Cartilage and Osteoarthritis
Pearle, A. D., Warren, R. F., & Rodeo, S. A. (2005) · Clinics in Sports Medicine · doi:10.1016/j.csm.2004.08.007 · Cited by 476
Expression profiling of metalloproteinases and their inhibitors in cartilage
Kevorkian, L., Young, D. A., Darrah, C., Donell, S. T., Shepstone, L., Porter, S., Brockbank, S. M. V., Edwards, D. R., Parker, A. E., & Clark, I. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11433 · Cited by 404
Osteoarthritis: An Overview of the Disease and Its Treatment Strategies
Sarzi-Puttini, P., Cimmino, M. A., Scarpa, R., Caporali, R., Parazzini, F., Zaninelli, A., Atzeni, F., & Canesi, B. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.013 · Cited by 400
Bau, B., Gebhard, P. M., Haag, J., Knorr, T., Bartnik, E., & Aigner, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10531 · Cited by 385
The role of aggrecan in normal and osteoarthritic cartilage
Roughley, P. J., & Mort, J. S. (2014) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-014-0008-7 · Cited by 377
Ghosh, P., & Guidolin, D. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.33720 · Cited by 369
Roach, H. I., Yamada, N., Cheung, K. S. C., Tilley, S., Clarke, N. M. P., Oreffo, R. O. C., Kokubun, S., & Bronner, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21300 · Cited by 351
Roles of Aggrecan, a Large Chondroitin Sulfate Proteoglycan, in Cartilage Structure and Function
Watanabe, H., Yamada, Y., & Kimata, K. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022166 · Cited by 327
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Murphy, G., & Nagase, H. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0727 · Cited by 316
Modulating hedgehog signaling can attenuate the severity of osteoarthritis
Lin, A. C., Seeto, B. L., Bartoszko, J. M., Khoury, M. A., Whetstone, H., Ho, L., Hsu, C., Ali, S. A., & Alman, B. A. (2009) · Nature Medicine · doi:10.1038/nm.2055 · Cited by 316
Hardy, M. M., Seibert, K., Manning, P. T., Currie, M. G., Woerner, B. M., Edwards, D., Koki, A., & Tripp, C. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10356 · Cited by 302
The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics
YASUDA, Y., KALETA, J., & BROMME, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.013 · Cited by 300
Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage
Malfait, A.-M., Liu, R.-Q., Ijiri, K., Komiya, S., & Tortorella, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200431200 · Cited by 294
Mechanisms involved in cartilage proteoglycan catabolism
Caterson, B., Flannery, C. R., Hughes, C. E., & Little, C. B. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00078-0 · Cited by 285
The Role of Cytokines as Inflammatory Mediators in Osteoarthritis: Lessons from Animal Models
Goldring, M. B. (1999) · Connective Tissue Research · doi:10.3109/03008209909005273 · Cited by 283
Etiology and Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2017) · Kelley and Firestein's Textbook of Rheumatology · doi:10.1016/b978-0-323-31696-5.00069-3 · Cited by 278
ADAMTS‐1 cleaves a cartilage proteoglycan, aggrecan
Kuno, K., Okada, Y., Kawashima, H., Nakamura, H., Miyasaka, M., Ohno, H., & Matsushima, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01854-8 · Cited by 273
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Lohmander, L. S., Atley, L. M., Pietka, T. A., & Eyre, D. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11326 · Cited by 263
Self-citationSondergaard, B. C., Wulf, H., Henriksen, K., Schaller, S., Oestergaard, S., Qvist, P., Tankó, L. B., Bagger, Y. Z., Christiansen, C., & Karsdal, M. A. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.01.014 · Cited by 88
Mercuri, F. A., Maciewicz, R. A., Tart, J., Last, K., & Fosang, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.42.33038 · Cited by 52
Madsen, S. H., Sumer, E. U., Bay-Jensen, A.-C., Sondergaard, B.-C., Qvist, P., & Karsdal, M. A. (2010) · Biomarkers · doi:10.3109/13547500903521810 · Cited by 29
CleavPredict: A platform for reasoning about matrix metalloproteinases proteolytic events.
Kumar, S., Ratnikov, B. I., Kazanov, M. D., Smith, J. W., & Cieplak, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127877 · Cited by 29
Metadata
- Authors
- Lark, M. W., Bayne, E. K., Flanagan, J., Harper, C. F., Hoerrner, L. A., Hutchinson, N. I., Singer, I. I., Donatelli, S. A., Weidner, J. R., Williams, H. R., Mumford, R. A., & Lohmander, L. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-07-01
- Volume
- 100
- Issue
- 1
- Pages
- 93-106
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2034919108
- Cited by
- 470
- References
- 38
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.